← Back to news
Y

Yahoo Finance

Barclays Analyst Is Bullish On Pacific Biosciences of California, Inc. (PACB)

Y

Cathie Wood’s ARK Investment Buys 755K Shares Of Recursion Pharmaceuticals, Inc. (RXRX)

Y

Chardan Maintains A Buy Recommendation On CRISPR Therapeutics AG (CRSP)

Y

Barclays Keeps Its Overweight Rating On Twist Bioscience Corporation (TWST)

Y

Morgan Stanley Initiates Coverage Of Veracyte, Inc. (VCYT)

Y

Canaccord Lowers Price Objective On Tempus AI, Inc. (TEM)

Y

What Do Analysts Think About GeneDx Holdings Corp. (WGS)?

Y

H.C. Wainwright Maintains A Buy Rating On Wave Life Sciences Ltd. (WVE)

Y

Prime Medicine, Inc. (PRME) Announces NEJM Publication Of PM359 Data

Y

China's CXMT eyes $4.2 billion Shanghai listing to fund DRAM expansion

Y

VNQI vs RWX: Broad International Property Exposure or Regional Concentration

Y

China Vanke's near-default exposes fragility of the faltering recovery in the property industry

Y

AMD's Lisa Su Pays Tribute To Former IBM CEO Lou Gerstner: An 'Amazingly Curious' Leader Who Shaped Her Early Career

Y

Wall Street falls in light trading on the final day of 2025, another banner year for markets

Y

Prediction: This Company Is All Set to Hit a $5 Trillion Market Cap in 2026 (Hint: It's Not Nvidia)

Y

Oil slips as Brent heads for longest stretch of annual losses in 2025

Y

Asia Market Open: Bitcoin Holds $88K as Regional Markets Dip In Thin Year-End Trade

Y

Intel Investors Just Got Great News for 2026

Y

Trading guru Peter Brandt warns winners of silver's epic rally to watch out

Y

Veteran analyst resets AI stock buy list for 2026

Y

Bitcoin's On-Chain Activity Slump Leads Analyst To Claim Apex Crypto's Shift From P2P Cash To Store Of Value

Y

OpenAI Is Paying Employees More Than Any Major Tech Startup in History

Y

Bankers Are Gearing Up for Another Onslaught of Monster Deals in 2026

Y

GPUs Are So 2025 -- This Is 2026's Hottest Trend for the $15.7 Trillion Artificial Intelligence Revolution

Y

Billionaire Chase Coleman Has More Than 10% of His Holdings in 1 AI Stock Well Positioned for 2026

Y

Silver Inches Closer To $85: Campbell Says Don't 'Buy Fresh,' But Accumulate Dip As China Looks To Restrict Metal

Y

Is Ford a Dividend Stock Worth Buying for 2026 After Its 34% Rise This Year?

Y

Footballer David Beckham-Backed Healthcare Firm Will no Longer Buy Bitcoin

Y

WAY: What does Argus have to say about WAY?

Y

SNX: Lowering target price to $169.00

Y

SNDK: Lowering target price to $252.00

Y

SEZL: Lowering target price to $62.00

Y

OPLN: What does Argus have to say about OPLN?

Y

NTNX: Lowering target price to $49.00

Y

NABL: What does Argus have to say about NABL?

Y

HLNE: Lowering target price to $150.00

Y

GRBK: What does Argus have to say about GRBK?

Y

FYBR: What does Argus have to say about FYBR?

Y

FDP: Lowering target price to $37.00

Y

CTRA: What does Argus have to say about CTRA?

Y

CNQ: Raising target price to $37.00

Y

BCPC: Lowering target price to $147.00

Y

BANC: Lowering target price to $21.00

Y

Argentina’s Shale Boom Propels It Past Colombia in Oil Output

Y

ARCB: Lowering target price to $79.00

Y

Why One Fund Has a $320 Million Bet on Workiva Stock Despite a 21% Share Slide

Y

7 Key Signs You’ll Be a Millionaire Sooner Than You Think

Y

Everus Stock Up 31% This Past Year -- but One Major Holder Cut Exposure by $1.5 Million

Y

Further rate cuts in question as Fed policymakers deeply divided over December cut, minutes show

Y